Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Chu

Showing results (211-220 of 228) with videos related to

Pageof 23
Sort By:
International Advances in Surgical Oncology|January 1, 1982
Prostatic acid phosphatase and prostate-specific antigen in prostate cancerM Kuriyama, R Loor, M C Wang, et al.
Cancer Research|February 1, 1985
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancerC S Killian, N Yang, L J Emrich, et al.
Progress in Clinical and Biological Research|January 1, 1980
The LNCaP cell line--a new model for studies on human prostatic carcinomaJ S Horoszewicz, S S Leong, T M Chu, et al.
Biomedical Materials (Bristol, England)|February 9, 2017
A fast-degrading thiol-acrylate based hydrogel for cranial regenerationA M Emmakah, H E Arman, J C Bragg, et al.
The Journal of Urology|August 1, 1977
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Journal of the National Cancer Institute|January 1, 1982
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigensM Kuriyama, M C Wang, C L Lee, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.
Pageof 23

Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
International Advances in Surgical Oncology|January 1, 1982
Prostatic acid phosphatase and prostate-specific antigen in prostate cancerM Kuriyama, R Loor, M C Wang, et al.
Cancer Research|February 1, 1985
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancerC S Killian, N Yang, L J Emrich, et al.
Progress in Clinical and Biological Research|January 1, 1980
The LNCaP cell line--a new model for studies on human prostatic carcinomaJ S Horoszewicz, S S Leong, T M Chu, et al.
Biomedical Materials (Bristol, England)|February 9, 2017
A fast-degrading thiol-acrylate based hydrogel for cranial regenerationA M Emmakah, H E Arman, J C Bragg, et al.
The Journal of Urology|August 1, 1977
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Journal of the National Cancer Institute|January 1, 1982
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigensM Kuriyama, M C Wang, C L Lee, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.
Pageof 23